Home
Browse
Search
Statistics
About
Usage
PMID: 20623213
Crouthamel MH, Wu D, Yang Z, Ho RJ
A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.
AAPS J. 2010 Dec;12(4):548-55. Epub 2010 Jul 10.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
0
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:0:42
status:
NEW
view ABCB1 p.Cys431Leu details
Research Article A Novel MDR1 GT1292-3TG (
Cys431Leu
) Genetic Variation and Its Effect on P-glycoprotein Biologic Functions Matthew H. Crouthamel,1 Daniel Wu,2 Ziping Yang,1,3 and Rodney J. Y. Ho1,4 Received 11 February 2010; accepted 18 June 2010; published online 10 July 2010 Abstract.
Login to comment
4
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:4:43
status:
NEW
view ABCB1 p.Cys431Leu details
We have identified a novel MDR1GT1292-3TG (
Cys431Leu
) genetic variation through systematic profiling of subjects with leukemia.
Login to comment
8
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:8:19
status:
NEW
view ABCB1 p.Cys431Leu details
The effects of the
Cys431Leu
variation, due to MDR1GT1292-3TG nucleotide transition, on P-gp-dependent intracellular substrate accumulation appeared to be substrate dependent where doxorubicin, vinblastine, and paclitaxel exhibit an increased accumulation (p<0.05), while verapamil and Hoechst33342 exhibit a decreased intracellular concentration compared with wild type (p<0.05).
Login to comment
30
ABCB1 p.Gly191Arg
X
ABCB1 p.Gly191Arg 20623213:30:11
status:
NEW
view ABCB1 p.Gly191Arg details
MDR1G571A (
Gly191Arg
) is located in the third transmembrane (TM) domain of P-gp and decreased resistance to vinblastine, vincristine, and paclitaxel with no significant difference with doxorubicin.
Login to comment
99
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:99:221
status:
NEW
view ABCB1 p.Cys431Leu details
Allelic Frequency of MDR1 1292-3 Variants in Leukemia Subjects Sequence/variation Amino acid variation Estimated allelic frequency in leukemia patients Copies per ng RNA Wild type Cys 431 0.9865 459±293 GT 1292-3 TG
Cys 431 Leu
0.0135 1126±137* The RNA from 74 leukemia patients was collected, and the MDR1 RNA transcripts were reverse transcribed into complementary DNA.
Login to comment
131
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:131:136
status:
NEW
view ABCB1 p.Cys431Leu details
White bars rhodamine123, black bars rhodamine123+GF120918 ATPase Activity ATPase activity was measured to determine if the change from
cysteine to leucine at amino acid 431
in the nucleotide binding domain (NBD) would alter the ability of P-gp to hydrolyze ATP to ADP.
Login to comment
135
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:135:158
status:
NEW
view ABCB1 p.Cys431Leu details
Based on our MDR1 sequence variation analysis, we discovered the novel MDR1GT1292-3TG nucleotide variation that translates to an amino acid substitution from
cysteine to leucine at position 431
.
Login to comment
137
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:137:96
status:
NEW
view ABCB1 p.Cys431Leu details
In this study, we used MDR1GT1292-3TG recombinant HEK cells that express a P-gp variant, with a
Cys to Leu substitution at amino acid 431
, to evaluate functional changes.
Login to comment
146
ABCB1 p.Cys431Ala
X
ABCB1 p.Cys431Ala 20623213:146:17
status:
NEW
view ABCB1 p.Cys431Ala details
In addition, the
Cys431Ala
mutation did not impact ATPase activity.
Login to comment
147
ABCB1 p.Cys431Ala
X
ABCB1 p.Cys431Ala 20623213:147:94
status:
NEW
view ABCB1 p.Cys431Ala details
When the cysteine was re-inserted at amino acid 431 as the only cysteine within the Cys-less (
Cys431Ala
) P-gp molecule, covalent modification of the thiol side chain with N-ethylmaleimide inhibited activity of P-gp, suggesting that both NBDs must be active for function (22).
Login to comment
156
ABCB1 p.Cys431Ala
X
ABCB1 p.Cys431Ala 20623213:156:32
status:
NEW
view ABCB1 p.Cys431Ala details
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:156:46
status:
NEW
view ABCB1 p.Cys431Leu details
Although a direct comparison of
Cys431Ala
and
Cys431Leu
with WT P-gp in HEK recombinant cells remained, such a study is beyond the scope of this report.
Login to comment
159
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:159:37
status:
NEW
view ABCB1 p.Cys431Leu details
Our cytotoxicity studies showed that
Cys431Leu
substitution resulted in a significant increase in sensitivity to chemotherapeutic drugs.
Login to comment
193
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:193:196
status:
NEW
view ABCB1 p.Cys431Leu details
The substrate-specific differences in intracellular accumulation do not appear to link with ATPase activity. Our studies of the ATPase activity showed no difference between the wild-type P-gp and
Cys431Leu
variant.
Login to comment
211
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:211:129
status:
NEW
view ABCB1 p.Cys431Leu details
In our MDR1GT1292-3TG variant, there are no amino acid changes within the TM segments; the MDR1GT1292-3TG variation results in a
Cys431Leu
substitution in the ATP binding domain.
Login to comment
213
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:213:24
status:
NEW
view ABCB1 p.Cys431Leu details
We hypothesize that the
Cys431Leu
change may affect the communication between the NBD and the TM domains, resulting in altered conformation of the TM segments during ATP binding and/or ATP hydrolysis.
Login to comment
218
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:218:32
status:
NEW
view ABCB1 p.Cys431Leu details
It must also be noted that this
Cys431Leu
variation is the result of two mutations occurring simultaneously at nucleotides 1292 and 1293.
Login to comment
220
ABCB1 p.Cys431Phe
X
ABCB1 p.Cys431Phe 20623213:220:86
status:
NEW
view ABCB1 p.Cys431Phe details
ABCB1 p.Cys431Trp
X
ABCB1 p.Cys431Trp 20623213:220:119
status:
NEW
view ABCB1 p.Cys431Trp details
If these mutations were to occur independently of one another, they would result in a
Cys431Phe
transition (G1292T) or
Cys431Trp
transition (T1293G).
Login to comment
222
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:222:276
status:
NEW
view ABCB1 p.Cys431Leu details
ABCB1 p.Cys431Phe
X
ABCB1 p.Cys431Phe 20623213:222:220
status:
NEW
view ABCB1 p.Cys431Phe details
ABCB1 p.Cys431Trp
X
ABCB1 p.Cys431Trp 20623213:222:234
status:
NEW
view ABCB1 p.Cys431Trp details
Regardless, if our hypothesis is correct in that the change in P-gp-mediated resistance and uptake is due to the increase in size and hydrophobicity of the resulting amino acid 431 compared with Cys, we believe that the
Cys431Phe
and
Cys431Trp
may have similar results to the
Cys431Leu
transition, and remains to be investigated.
Login to comment
223
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:223:57
status:
NEW
view ABCB1 p.Cys431Leu details
CONCLUSION We investigated a novel human MDR1GT1292-3TG (
Cys431Leu
) variation.
Login to comment
226
ABCB1 p.Cys431Leu
X
ABCB1 p.Cys431Leu 20623213:226:50
status:
NEW
view ABCB1 p.Cys431Leu details
Drug uptake studies showed that the effect of the
Cys431Leu
variation results in a substrate-specific effect where doxorubicin, vinblastine, and paclitaxel had an increased uptake, while verapamil and Hoechst33342 had a decreased uptake compared with wild type.
Login to comment